SUMMARY The monoclonal antibody AGF4-48 detects the 3-fucosyl-N-acetyllactosamine carbohydrate structure and reacts with a variety of human tissues, as shown by an immunoperoxidase method on paraffin sections of formalin fixed material. The intensity and distribution of the immunoperoxidase reactivity were affected by treatment of sections with neuraminidase. In some sites, such as bone marrow, brain, breast, and pituitary, the reaction was more intense after neuraminidase treatment. In several organs, including kidney, oesophagus, pancreas, submandibular gland, and uterus, the reaction was more widespread after neuraminidase treatment.
Little is known about the functions of particular sugar sequences within carbohydrate chains of cell surface and secreted glycoproteins or glycolipids. One aid to the understanding of this problem is to determine the precise distribution of specific carbohydrate structures within tissues. Some monoclonal antibodies to carbohydrate antigens can be used for such a study as the chemical structure of the determinant they recognise has been discovered. For instance, the monoclonal antibodies VEP8,' VEP9,' My-1,2 and IG103 detect the carbohydrate group 3-fucosyl-N-acetyllactosamine, which has the structure:
,f-D-galactose 1.4 (a-L-fucose 1-+3) N-acetyl-D-glucosamine. We have shown that another monoclonal antibody, AGF4-48, now known to react with 3-fucosyl-N-acetyllactosamine (T Feizi and HC Gooi, personal communication), can be used in immunohistological studies of formalin fixed, paraffin embedded tissues. 4 We showed widespread distribution in human tissues of this antigenic determinant. Cells stained included proximal Accepted for publication 4 December 1984 tubules and thin limbs in the kidney, parietal cells in the stomach, a variety of other epithelial cells, astrocytes in the brain, and corticotrophs in the anterior pituitary.
Terminal galactose residues in carbohydrates are often sialylated by the addition of neuraminic acid residues.5 Furthermore, the 3-fucosyl-N-acetyllactosamine structure may not be detected in antibody binding studies because of steric hindrance by neuraminic acid residues.' Thus it was interesting to see whether removal of terminal neuraminic acid residues with the enzyme neuraminidase affected the immunohistological demonstration of 3-fucosyl-N-acetyllactosamine.
Material and methods
The mouse monoclonal antibody AFG4-48, raised against the human promyeloid cell line HL60, has been described previously.46 For immunohistology AGF4-48 hybridoma culture supernatant was used undiluted.
Fresh samples of normal human tissues, listed in the Tables, were obtained from surgical specimens  409 Table 1 Effect ofneuraminidase on reactivity of tissues  with monoclonal antibody AGF4-48   Tissues not stained by AGF4-48 even after neuraminidase treatment   Adrenal, islets of Langerhans, parathyroid, thyroid  Ovary, testis, Preliminary experiments showed that the enzyme was effective at concentrations of 1 U/ml and 5 U/ml and that incubation times of 1-2 h at room temperature were as effective as 1 h at 37°C. Generally the enzyme was used at 1 U/ml for 1-5 h at room temperature. 
Results
Sections incubated with AGF4.48 antibody that had been adsorbed with HL60 cells showed no staining by the peroxidase conjugated second antibody reagent whether or not the sections had been treated with neuraminidase. Control sections treated with veronal acetate buffer, pH 5-0, gave the same distribution of staining with AGF4-48 antibody as described previously. 4 Neuraminidase treatment of sections affected the intensity and distribution of staining with AGF4-48 antibody in many tissues, although as noted in Table  1 the enzyme had little or no effect on the staining of some tissues. Tissues on which neuraminidase had no effect included some reactive with AGF4A48 antibody, such as gastric mucosa, and some unreactive with the antibody, such as thyroid. As noted in Table 1 , the enzyme increased the intensity of staining of cytoplasmic granules of corticotrophs, astrocyte cell bodies and their processes, gall bladder epithelium and mucus in goblet cells, acini and milk in breast, and neutrophils, which showed peripheral accentuation and sometimes a granular intracytoplasmic reaction. Table 2 lists those organs in which reactivity with Effect of neuraminidase on the expression of the 3-fucosyl-N-acetyllactosamine antigen in human tissues 411 AGF4-48 antibody was more widespread after enzyme treatment and also those organs in which reactivity became apparent only after neuraminidase treatment. Some different staining patterns observed on control and neuraminidase treated sections are also illustrated in Figs. 1-11 .
The cell membrane of hepatocytes was not stained by AGF4-48 antibody in control sections but became strongly positive after neuraminidase treatment ( Figs. 1 and 2) . A similar but less striking change was seen in acinar cells of pancreas and submandibular gland. In kidney neuraminidase treatment affected the reactivity in that all proximal tubules were positive, not just those in the deep cortex (Figs. 3 and 4) . In addition the enzyme increased the extent of staining-of the transitional epithelium in the kidney, ureter, and bladder, and of stratified squamous epithelium in mucous membranes of the oesophagus, cervix, and tonsil.
Some glandular cells were either negative or incompletely positive in control sections but became uniformly positive after neuraminidase treatment; these included glands in the oesophagus and bronchus (Figs. 5 and 6 ) and endometrium. The cilia of some epithelial cells in the uterine tube became positive after enzyme treatment (Figs. 7 and 8 ).
In the skin there was only a slight increase in staining of the stratified squamous epithelium after neuraminidase treatment but Langerhans' cells in the epidermis and dermis became strongly positive, their cell bodies and dendritic processes being well shown (Figs. 9 and 10 ). $imilar cells were seen in tonsillar crypt epithelium and in thymus and lymph node, in which they were probably interdigitating reticulum cells (Fig. 1 1) .
Discussion
Several monoclonal antibodies have been shown to react with 3-fucosyl-N-acetyllactosamine. These include some antibodies like AGF4-48 raised against myeloid cells'-' and also some raised against various carcinomas.7-9 The monoclonal antibody to stage specific embryonic antigen I (SSEA-I) is against the same determinant.'0 An immunohistological study with this antibody using unfixed sections gave results corresponding to those obtained in the present study when untreated sections were stained by AGF4-48 antibody, except that adrenal medulla and neurones were reported to be positive in the study of SSEA-I."
In this study we investigated whether the 3-fucosyl-N-acetyllactosamine antigen is cryptic and masked by neuraminic acid in various tissues by pretreating sections with neuraminidase before staining with AGF4-48 antibody. Neuraminidase treatment ' , .+.9.. of tissue sections caused striking changes in the intensity and distribution of staining by AGF4-48 antibody. The results showed that 3-fucosyl-N-acetyllactosamine is obscured by neuraminic acid to a variable extent in different organs and, to a variable extent, even in different parts of the same organ-for example, the kidney. The 3-fucosyl-N-acetyllactosamine antigen may be masked by neuraminic acid in two ways. One explanation of the effect of neuraminidase on the distribution of staining by AGF4*48 is that the enzyme is removing terminal neuraminic acid residues from 3-fucosyl-N-acetyllactosamine chains. Alternatively, neuraminidase is removing neuraminic acid residues from adjacent carbohydrate chains, which when sialylated obscure 3-fucosyl-N-acetyllactosamine by steric hindrance. A sialylated form of 3-fucosyl-N-acetyllactosamine does occur in human tissues. A glycolipid has been isolated from the kidney which has an Nacetyl-D-neuraminic acid residue on the 3-carbon position of the galactose part of 3-fucosyl-N-acetyllactosamine.'2 In kidney AGF4-48 staining became strongly positive and more widespread after sections were treated with neuraminidase. The pronounced change may be related to removal of neuraminic acid residues from this glycolipid. Monoclonal antibodies which specifically recognise the sialylated form of 3- fucosyl-N-acetyllactosamine would be useful for investigating whether this antigen is masked by the addition of terminal neuraminic acid or by such residues on adjacent side chains. These are not yet available, although antibodies which react with other sialylated saccharides, such as the monoclonal antibodies Cal,'3 1 ' 19_9,'5 and 4 2,'6 have been reported.
The cryptic nature of the 3- fucosyl-N-acetyllactosamine saccharide in antibody binding studies illustrates a difficulty in using monoclonal antibodies to determine the precise occurrence of particular carbohydrate structures and thus ..V. 
